← Research library

Pielotax: clinical report on a tissue-derived preparation

Comparison in people · 2011

What was studied
Gouty nephropathy: 27 treated, 15 controls.
Main finding
After 30 days, blood urate was 0.44 versus 0.56 mmol/L in men and 0.37 versus 0.48 mmol/L in women, comparing adjunctive Pielotax with conventional treatment.

Blood urate in men · 0.44 ± 0.02 mmol/L with Pielotax versus 0.56 ± 0.01 mmol/L with conventional care.

Reported findings and study design

42 participants with gouty nephropathy: 27 received one to two Pielotax capsules three times daily before meals for 30 days alongside conventional therapy, and 15 received conventional therapy. The report describes random assignment without explaining how it was performed.

Population or model Gouty nephropathy: 27 treated, 15 controls.

Results · Medical Center report, PDF pages 44–45, Tables 1–2
MeasureResultComparison, timing and statistics
Blood urate in men0.44 ± 0.02 mmol/L with Pielotax versus 0.56 ± 0.01 mmol/L with conventional care.
Blood urate in women0.37 ± 0.03 mmol/L with Pielotax versus 0.48 ± 0.02 mmol/L with conventional care.
Residual nitrogen27.1 ± 0.4 mmol/L with Pielotax versus 30.5 ± 0.6 mmol/L with conventional care.The table marks p < 0.05 versus conventional care.

The report measured short-term laboratory markers and gives no detailed adverse-event assessment.

Source for these results ↗ · Reviewed 2026-11-16

Study limitations and source details

Study limitations

  • Sequence generation, concealment and long-term outcomes remain unresolved. Laboratory-marker changes do not establish prevention of kidney failure.
  • Commercially reproduced institute report; independent peer review and independent replication are not established by this document.
  • Short-term reporting without a complete adverse-event protocol cannot establish long-term safety. Preparation equivalence to current products or synthetic peptides is unproven.

Source details

Institute report — commercial reproduction

English compilation, PDF pages 43 onward; selected report text/tables checked. Russian original not reconciled.

Sources checked

Citation

Report attributed to · Medical Center, St. Petersburg Institute of Bioregulation and Gerontology

Human comparative studyFull text available

St. Petersburg Institute of Bioregulation and Gerontology Medical Center (report attribution). Pielotax: clinical report on a tissue-derived preparation Institute clinical report (commercial reproduction); 2011 study/report date, not website publication date

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards